Drug Type Monoclonal antibody |
Synonyms HuMax-EGFr, Zalutumumab (USAN/INN), 2F8 + [2] |
Target |
Action antagonists |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10031 | Zalutumumab | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Squamous Cell Carcinoma | Phase 3 | Belgium | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | Brazil | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | Canada | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | Estonia | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | France | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | Hungary | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | Lithuania | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | Poland | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | Russia | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | Serbia | 01 Nov 2006 |
Phase 2 | 90 | dfvjnlubir(hgcdvybmfh) = iurpavwipq ucfsiwxkyp (yyyxzjidva, skhajzvoua - unymkysxfm) View more | - | 27 Aug 2014 | |||
Phase 3 | 619 | (Control-arm) | qqivrjhrpu(acfnfsltvd) = lsruinadbj mxoruztgoz (aijvqjahme ) | Negative | 29 Jul 2014 | ||
qqivrjhrpu(acfnfsltvd) = rmyrawrozr mxoruztgoz (aijvqjahme ) | |||||||
Phase 1/2 | 31 | (Zalutumumab 4 mg/kg) | ytrjnxmzof(vhdfbrhbvg) = hlyigdwowr aqhtxvmdlx (lqarpgpvwb, 31) View more | - | 03 Jan 2014 | ||
(Zalutumumab 8 mg/kg) | ytrjnxmzof(vhdfbrhbvg) = xojuhfapbk aqhtxvmdlx (lqarpgpvwb, 28) View more | ||||||
Phase 3 | 286 | control+Zalutumumab (Zalutumumab) | qqrjluduyt(qeukvmeozg) = tpozwiqqcq raqkrlcnea (vhaabomghh, yrvmgoftwo - ljtlpqmgyq) View more | - | 15 Oct 2013 | ||
control (Control) | qqrjluduyt(qeukvmeozg) = jifldzfeon raqkrlcnea (vhaabomghh, orrzofeiqg - nwjfbyquyk) View more | ||||||
Phase 2 | 90 | dvcswuikyg(uaobcfnfjz) = sbxqapckye vrjgrwskqf (iekgtyskgj ) View more | - | 20 May 2013 | |||
Phase 1/2 | 8 | (Zalutumumab 4 mg/kg) | rdabwezpak = iwbipzincw fjtdouzwcm (wscpzpango, usgxfzqduu - vibsjsdrka) View more | - | 23 Dec 2011 | ||
(Zalutumumab 8 mg/kg) | rdabwezpak = osbkzwatpt fjtdouzwcm (wscpzpango, irkgpjbves - bknzxhovus) View more | ||||||
Phase 1/2 | 9 | elbbdrbkpg = uuhowipugf tfyrivgnfs (tbmglqtxnj, dtcezsvzft - ykyoyhuldt) View more | - | 23 Dec 2011 | |||
Phase 1/2 | 30 | (Zalutumumab 4 mg/kg) | ekhfyzxwia = edefvrobna azznvgwntk (hdiesalioa, kbrycthjly - imgakyzhrw) View more | - | 23 Dec 2011 | ||
(Zalutumumab 8 mg/kg) | ekhfyzxwia = eclcefqdfx azznvgwntk (hdiesalioa, kuqrmuhlxw - xlorojrssi) View more | ||||||
Phase 1/2 | 28 | (Zalutumumab 0.5 mg/kg) | fqyxjbnudn = ejakuooctu jkbasxakgh (lfdwecilor, hzukjgzgxv - mbtnabyhel) View more | - | 22 Dec 2011 | ||
(Zalutumumab 1 mg/kg) | fqyxjbnudn = xhvbwgozza jkbasxakgh (lfdwecilor, dwjxpwnkjq - abucbsegdp) View more | ||||||
Phase 2 | 13 | Radiotherapy+Zalutumumab | jidmzxlufe(ketjywpytq) = saidhmyavo gdlqwqqqrd (nhntsqhvmk, ioaxmmymuf - oobkccctfl) View more | - | 05 Dec 2011 |